SIBNSIBNHealthcare · Medical Devices

SIBN Stock Forecast: SI-BONE, Inc. Price Predictions for 2026-2027

Last close, 20 Nov 2026
$24
−0.04% on the day

The 9 Wall Street analysts covering SI-BONE, Inc. hold a median 12-month price target of $26 — +9.5% from the last close. Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 85 of 100 as at 21 Nov 2026 — inside the top quartile. Here, the model and the Street point the same way.

Market cap
$1.1B
Ticker Nerd rank
85/ 100
Median analyst target
$26
Analysts covering
9
Revenue$56.0M+15.2% y/y
Operating income−$4.8M
Net income−$4.1M
Free cash flow−$768K
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
+1.3%
1M
+15.6%
YTD
+20.4%
1Y
+27.1%
From 52W high
−7.3%
From 52W low
+104.5%
$12
$26
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

One number for the whole business

Consensus tells you what everyone already believes. The model scores SI-BONE, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 21 Nov 2026
85/ 100

Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Revisions
93
Quality
85
Momentum
79
Volatility
79
Accruals
62
Growth
61
Value
52
Issuance
28

Revisions (93): Analysts have, on balance, been raising their forecasts.

Issuance (28): The company has been issuing shares or taking on financing, diluting existing holders.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

SIBN stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on SIBN, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$10$15$20$25$30Jan 26Apr 26Jul 26Oct 26SIBNHigh $32Median $26Low $23

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says9 analysts
9
Buy
0
Hold
0
Sell
$23
Low
$26
Median
$32
High

The green dot is the last close — the median target sits +9.5% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 7 moved their price target up and 3 moved it down.

DateFirmActionRatingTarget
3 Nov 2026NeedhamMaintainsBuy$27 → $26
3 Nov 2026TD CowenMaintainsBuy$20 → $23
3 Nov 2026UBSMaintainsBuy$25 → $26
14 Oct 2026Truist SecuritiesMaintainsBuy$23 → $25
4 Aug 2026TD CowenMaintainsBuy$18 → $20
4 Aug 2026Truist SecuritiesReiteratesBuy$21 → $23
4 Aug 2026UBSMaintainsBuy$24 → $25
28 July 2026UBSInitiatesBuy$24
16 July 2026Truist SecuritiesMaintainsBuy$18 → $21
12 May 2026TD CowenMaintainsBuy$22 → $18
12 May 2026Truist SecuritiesReiteratesBuy$20 → $18
15 Apr 2026Truist SecuritiesMaintainsBuy—
24 Feb 2026TD CowenMaintainsBuy—
24 Feb 2026Truist SecuritiesReiteratesBuy—
27 Jan 2026TD CowenInitiatesBuy—
18 Dec 2025Truist SecuritiesMaintainsBuy—
17 Dec 2025Canaccord GenuityMaintainsBuy—
16 Dec 2025NeedhamMaintainsBuy—
2 Dec 2025Morgan StanleyMaintainsOverweight—
15 Oct 2025Truist SecuritiesMaintainsBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Wall Street targets run 12 to 18 months out. No analyst publishes a 2030 price target for SIBN.

Market Radar

This page is one stock. Monday covers all of them.

SIBN appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.

Free. Unsubscribe any time. Privacy

The AI build-out map
PDF
  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and servers

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Performance

SIBN vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 20 Nov 2026, SI-BONE, Inc. returned +27.1% against +6.9% for the S&P 500, dividends included.

SIBN vs S&P 500, last 12 monthsTotal return, rebased to 100
6080100120140Jan 26Apr 26Jul 26Oct 26SIBNS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

SIBN analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingThis fiscal year
Analysts raising
5
Analysts cutting
0
Fundamentals

Financials

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
—
Price / sales
4.9×

Cheaper than 22% of US stocks

Price / book
5.8×

Cheaper than 15% of US stocks

EV / EBITDA
—
Growth & margins
Revenue growth (YoY)
14.5%

Higher than 63% of US stocks

Earnings growth (YoY)
—
Gross margin
79.5%

Higher than 90% of US stocks

Operating margin
−7.6%

Higher than 28% of US stocks

Net margin
−6.2%

Higher than 24% of US stocks

Returns & dividend
Return on equity
−7.7%

Higher than 38% of US stocks

Return on assets
−4.3%

Higher than 33% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.

Statistics

Key statistics

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • SI-BONE, Inc. has a market value of $1.1B and an enterprise value of $967.1M.

  • Revenue in the twelve months to 30 June 2026: $213.6M. The latest quarter grew 15.2% year on year.

  • Net income over the same four quarters: −$14.6M, a −6.9% net margin.

  • Diluted earnings per share, trailing twelve months: −$0.34.

  • Free cash flow in the twelve months to 30 June 2026: −$4.4M.

  • Shares outstanding: 44.7M.

  • SI-BONE, Inc. employs 376 people — $568K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 22 Nov 2026

Data provided by Twelve Data

Peers

SIBN and its peers

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Devices
CompanyMarket capTKN rank
SIBNSI-BONE, Inc.$1.1B85
IRMDIRadimed Corp.$1.0B80
CBLLCeribell, Inc.$1.1B44
IARTIntegra LifeSciences Holdings Corp.$1.0B81
ATECAlphatec Holdings, Inc.$1.0B63
AHCOAdaptHealth Corp.$978.6M68
TNDMTandem Diabetes Care, Inc.$1.2B66

Take a look at SIBN’s peer groups, ranked by the model: healthcare stocks.

Look up any of the roughly 4,300 stocks we score.

The rank is the raw material. Whether the rules would actually own SI-BONE, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

FAQ

Questions about SIBN

What is the SIBN stock price forecast for 2026-2027?

The 9 Wall Street analysts covering SI-BONE, Inc. have a median 12-month price target of $26, with estimates ranging from $23 to $32. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is SIBN stock a buy right now?

Of the 9 analysts covering SI-BONE, Inc., 9 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks SI-BONE, Inc. 85 out of 100 across roughly 4,300 US stocks as at 21 Nov 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank SIBN?

As at 21 Nov 2026, SI-BONE, Inc. ranks 85 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Revisions (93 of 100).

Will SIBN stock go up?

No one can know that. What the data says: the median 12-month target from 9 analysts implies +9.5% from the last close, and Ticker Nerd's factor model ranks SI-BONE, Inc. 85 out of 100 as at 21 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the SIBN stock forecast for 2030?

No analyst covering SI-BONE, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for SIBN are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $23 to $32 over the next 12 months.

How has SIBN stock performed over the past year?

SI-BONE, Inc. returned +27.1% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.

What does SI-BONE, Inc. do?

SI-BONE, Inc. is a medical device company focused on developing procedural solutions for musculoskeletal disorders of the sacropelvic anatomy. SI-BONE’s product portfolio centers on minimally invasive implant systems designed for sacroiliac joint fusion, pelvic fixation, and related orthopedic applications.

Company

About SI-BONE, Inc.

SI-BONE, Inc. is a medical device company focused on developing procedural solutions for musculoskeletal disorders of the sacropelvic anatomy. SI-BONE’s product portfolio centers on minimally invasive implant systems designed for sacroiliac joint fusion, pelvic fixation, and related orthopedic applications. Its offerings include patented titanium implants, surgical instruments, and implantable bone products used in procedures addressing sacroiliac joint dysfunction, pelvic trauma, and spinopelvic reconstruction. The company serves physicians and hospitals in the United States and selected international markets, supporting treatment workflows through direct sales and third-party distribution channels. Based in Santa Clara, California, SI-BONE plays a specialized role in the orthopedics and spine market by providing anatomy-specific technologies for patients with complex bone and joint conditions.

CEO Ms. Laura A. Francis MBA · 376 employees · United States · https://si-bone.com